Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 283, pseudogene (RNU6-283P) is a non-coding RNA pseudogene derived from the U6 small nuclear RNA gene family. U6 small nuclear RNAs are highly conserved components of the spliceosome, playing a key role in intron removal during pre-mRNA splicing. However, as a pseudogene, RNU6-283P does not produce a functional RNA or protein product and has no established biological or clinical role. Its existence reflects genomic duplication events; many U6 snRNA pseudogenes are present in vertebrate genomes and are considered non-functional. This molecule is not a receptor, enzyme, or therapeutic target. Its only active function is as a reference for genomic annotation or evolutionary study. Multiple alternative names exist due to annotation differences across databases. Pseudogenes like RNU6-283P are not used as biomarkers, nor do they interact with drugs or have known disease associations.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 283, pseudogene (RNU6-283P).